According to our (Global Info Research) latest study, the global Heparin Sodium API and Heparin Calcium API market size was valued at US$ 3848 million in 2025 and is forecast to a readjusted size of US$ 8596 million by 2032 with a CAGR of 12.3% during review period.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.
The heparin market is primarily driven by its extensive use as an anticoagulant in various medical applications. Heparin plays a critical role in preventing blood clot formation and is widely used during surgeries, dialysis procedures, and in the treatment and prevention of deep vein thrombosis and pulmonary embolism. Additionally, the increasing prevalence of cardiovascular diseases and the growing aging population contribute to the rising demand for heparin. However, the market also faces challenges, including the complex manufacturing process of heparin from animal sources, such as pig intestines. Ensuring a stable and safe supply of heparin can be challenging, especially during outbreaks of animal diseases that may impact the availability of raw materials. Moreover, there have been instances of adulteration and contamination of heparin products in the past, necessitating stringent quality control and safety measures. To overcome these challenges, the industry is exploring alternative sources of heparin, such as synthetic and biosynthetic production methods, to reduce reliance on animal-derived heparin and enhance supply chain resilience. Collaborative efforts between regulatory bodies, manufacturers, and healthcare providers are essential to ensure the availability of safe and high-quality heparin and drive the growth of the heparin market while addressing concerns related to sourcing, production, and patient safety.
This report is a detailed and comprehensive analysis for global Heparin Sodium API and Heparin Calcium API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Heparin Sodium API and Heparin Calcium API market size and forecasts, in consumption value ($ Million), sales quantity (Billion Units), and average selling prices (US$/Billion Units), 2021-2032
Global Heparin Sodium API and Heparin Calcium API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Billion Units), and average selling prices (US$/Billion Units), 2021-2032
Global Heparin Sodium API and Heparin Calcium API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Billion Units), and average selling prices (US$/Billion Units), 2021-2032
Global Heparin Sodium API and Heparin Calcium API market shares of main players, shipments in revenue ($ Million), sales quantity (Billion Units), and ASP (US$/Billion Units), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Heparin Sodium API and Heparin Calcium API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Heparin Sodium API and Heparin Calcium API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, Dongying Tiandong Pharmaceutical, Opocrin, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Heparin Sodium API and Heparin Calcium API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Heparin Sodium
Heparin Calcium
Market segment by Application
UFH
LMWH
Major players covered
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin Sodium API and Heparin Calcium API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heparin Sodium API and Heparin Calcium API, with price, sales quantity, revenue, and global market share of Heparin Sodium API and Heparin Calcium API from 2021 to 2026.
Chapter 3, the Heparin Sodium API and Heparin Calcium API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin Sodium API and Heparin Calcium API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Heparin Sodium API and Heparin Calcium API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin Sodium API and Heparin Calcium API.
Chapter 14 and 15, to describe Heparin Sodium API and Heparin Calcium API sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Heparin Sodium API and Heparin Calcium API. Industry analysis & Market Report on Heparin Sodium API and Heparin Calcium API is a syndicated market report, published as Global Heparin Sodium API and Heparin Calcium API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Heparin Sodium API and Heparin Calcium API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.